Long‐term fluoxetine administration does not result in major changes in bone architecture and strength in growing rats
- 12 December 2006
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 101 (2) , 360-368
Abstract
Many studies have indicated that serotonin and its transporter play a role in bone metabolism. In this study we investigated the effect of selective serotonin re‐uptake inhibitor (SSRI), fluoxetine (Prozac®) on bone architecture and quality in growing female rats. We therefore administrated rats with clinically relevant doses of fluoxetine for a period of 6 months. DXA scans were performed during the treatment period in order to follow parameters as body weight, fat percentage and BMD. After 6 months of treatment, femurs were used to analyze bone architecture and bone strength, by means of µCT scans and three‐point bending assays, respectively. We found a slightly diminished bone quality, reflected in a lower bone tissue strength, which was compensated by changes in bone geometry. As leptin and adiponectin could be possible factors in the serotonergic regulation of bone metabolism, we also determined the levels of these factors in plasma samples of all animals. Leptin and adiponectin levels were not different between the control group and fluoxetine‐treated group, indicating that these factors were not involved in the observed changes in bone geometry and quality. J. Cell. Biochem. 101: 360–368, 2007.Keywords
This publication has 32 references indexed in Scilit:
- Serotonin and fluoxetine modulate bone cell function in vitroJournal of Cellular Biochemistry, 2006
- Long‐term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in ratsJournal of Cellular Biochemistry, 2005
- Adiponectin increases bone mass by suppressing osteoclast and activating osteoblastBiochemical and Biophysical Research Communications, 2005
- Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivoMagnetic Resonance Materials in Physics, Biology and Medicine, 2004
- Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptakeBone, 2001
- Expression of Serotonin Receptors in BoneJournal of Biological Chemistry, 2001
- Leptin Inhibits Bone Formation through a Hypothalamic RelayCell, 2000
- A new method for the model‐independent assessment of thickness in three‐dimensional imagesJournal of Microscopy, 1997
- Quantification of Bone Microarchitecture with the Structure Model IndexComputer Methods in Biomechanics and Biomedical Engineering, 1997
- Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic.Journal of Histochemistry & Cytochemistry, 1987